SpudGene
@spudgene.com
Our Products Psilocybin API Lung Cancer Treatment Hypochlorous R&D Focus Areas The Research and Development management forms the foundation of our scientific activities and outlines the path to achieving practical outcomes. The Spud Gene R&D team is actively engaged in various fields, including pharmacology, biotechnology, and emerging medical sciences. The objective of our research endeavors
SpudGene's Company Logos


SpudGene's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#31708F
Calypso
49, 112, 143
200, 49, 38
66, 22, 0, 44
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#082B31
Tiber
8, 43, 49
189, 72, 11
84, 12, 0, 81
About SpudGene
Spud Gene, founded in 2021, is a pioneering brand committed to revolutionizing healthcare through cutting-edge science and technological advancements. Our diverse team of experts in biotechnology, artificial intelligence, engineering, and medicine collaborates to develop state-of-the-art pharmaceutical products aimed at combating incurable diseases.
Our relentless pursuit of innovative medicines led to groundbreaking achievements such as producing Psilocybin for psychiatric disorders, developing lung cancer treatments, and formulating FDA-approved skin repair solutions. By focusing on oncology, obesity, autoimmune diseases, and infectious diseases, we strive to make a lasting impact on global healthcare.
Driven by our vision to be a leading global biopharmaceutical manufacturer, we aim to set new industry standards with a commitment to deep research and innovative drug development. Through our mission of pioneering diagnostic methods and treatments using data science and AI, we aspire to reshape the landscape of therapeutic advancements and enhance patient lives worldwide.
At Spud Gene, our core values of science, technology, and team culture shape our strategy, driving us towards our goal of pushing the boundaries of the pharmaceutical industry to create a healthier future for all.
Company type
Privately Held
Year founded
2022
Company size
201-500 employees
